Recombinant CPT1B antibody
Quick Overview for Recombinant CPT1B antibody (ABIN7828065)
Target
See all CPT1B AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Recombinant CPT1B Monoclonal Antibody
-
Purification
- Protein A purified
-
Immunogen
- Recombinant human CPT1B fragment
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
- WB 1:1000-1:5000,IHC 1:50
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
-
Expiry Date
- 12 months
-
-
- CPT1B (Carnitine Palmitoyltransferase 1B (Muscle) (CPT1B))
-
Alternative Name
- CPT1B
-
Background
- KIAA,KIAA1670,CPT1B,CPT I,CPT1-M,CPTI-M,Carnitine palmitoyltransferase-1 (CPT1), localized to the mitochondrial outer membrane, translocates fatty acids across the mitochondrial membranes and catalyzes the rate-limiting step of β-oxidation. There are three isoforms of this enzyme: CPT1A (liver), CPT1B (muscle), and CPT1C (brain). Deficiency of CPT1A results in an autosomal recessive mitochondrial fatty acid oxidation disorder. Studies have shown that physiological high blood glucose and insulin levels inhibit CPT1B activity in human muscle and therefore divert long-chain fatty acids toward storage in human muscle as triglycerides. Furthermore, mice deficient in CPT1C show less food intake and reduced body weight. These findings suggest that CPT1 may play a role in metabolic syndromes. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [
-
Molecular Weight
-
Calculated MW: 87 kDa
Observed MW: 87 kDa
-
UniProt
- Q92523
-
Pathways
- AMPK Signaling, Monocarboxylic Acid Catabolic Process
Target
-